Results 221 to 230 of about 7,765,653 (401)

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Trends and patterns of complementary and alternative medicine use among cancer patients in Jordan: a decade comparison. [PDF]

BMC Complement Med Ther
Al-Rawashdeh N, Alqudimat M, Alananzeh I, Kasasbeh N, Ammar K, Al-Omari A.   +5 more
europepmc   +1 more source

Differential effects of acupuncture on clinic and 24 hour ambulatory blood pressure: the need for high standards in alternative medicine research [PDF]

, 2001
Robert Robinson
openalex   +1 more source

Complementary and Alternative Medicine [PDF]

Journal of Pain & Palliative Care Pharmacotherapy, 2002
openaire   +3 more sources

Multi‐omic profiling of squamous cell lung cancer identifies metabolites and related genes associated with squamous cell carcinoma

Molecular Oncology, EarlyView.
Using multi‐omic characterization, we aimed to identify key regulators specific to squamous cell lung carcinoma (SqCC). SqCC‐specific differentially expressed genes were integrated with metabolics data. High expression of the creatine transporter SLC6A8, along with elevated creatine levels, appeared to be a distinct metabolic feature of SqCC.
Johan Staaf, Daniel Ehinger, Hans Brunnström, Mats Jönsson, Frida Rosengren, Marija Kotevska, Anna Karlsson, Mattias Aine, Christian Frezza, Maria Planck, Elsa Arbajian   +10 more
wiley   +1 more source

Attitudes and use of complementary and alternative medicine: a cross-sectional comparison between medical and non-medical students. [PDF]

Front Pharmacol
Zakeri M, Dehghan M, Soltanmoradi Y, Monfared S, Kose G, Farahmandnia H, Hermis AH, Xu X, Zakeri MA.   +8 more
europepmc   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Complementary and Alternative Medicine in Midwifery [PDF]

, 2014
Abedzadeh-Kalahroudi, M.
core   +1 more source

The ACCEPTance of automation: refining circulating tumor cells enumeration for improved metastatic colorectal cancer prognosis

Molecular Oncology, EarlyView.
This study highlights the potential of automated enumeration using the ACCEPT software to refine circulating tumor cell (CTC) detection in metastatic colorectal cancer (mCRC). The automated method demonstrates improved accuracy and reduced variability compared to the manual approach.
Michela De Meo, Marco Siringo, Alessandro Vici, Ann Zeuner, Orietta Gandini, Paola Gazzaniga, Chiara Nicolazzo   +6 more
wiley   +1 more source

Antimicrobial properties and toxicity challenges of chlorine dioxide used in alternative medicine. [PDF]

Sci Rep
Dudek-Wicher R, Brożyna M, Paleczny J, Mączyńska B, Dudek B, Migdał P, Dołowacka-Jóźwiak A, Fischer J, Junka A.   +8 more
europepmc   +1 more source